Treatment of malignant pancreatic neuroendocrine neoplasms: middle-term (2-year) outcomes of a prospective observational multicentre study

Guido Rindi; Alessandro Zerbi; Vanessa Capitanio; Letizia Boninsegna; Gianfranco Delle Fave; Claudio Pasquali; Davide Campana; Massimo Falconi

doi:10.1111/hpb.12065

Treatment of malignant pancreatic neuroendocrine neoplasms: middle-term (2-year) outcomes of a prospective observational multicentre study

Guido Rindi, Alessandro Zerbi, Vanessa Capitanio, Letizia Boninsegna, Gianfranco Delle Fave, Claudio Pasquali, Davide Campana, Massimo Falconi

Risultato della ricerca: Contributo in rivista › Articolo in rivista › peer review

12 Citazioni (Scopus)

Abstract

Information on malignant pancreatic neuroendocrine neoplasms (pNENs) is mostly from retrospective studies in highly selected patients. The aim of this prospective, multicentre study was to assess treatment and outcomes of malignant pNENs in clinical practice.

Lingua originale	English
pagine (da-a)	935-943
Numero di pagine	9
Rivista	HPB
Volume	15
DOI	https://doi.org/10.1111/hpb.12065
Stato di pubblicazione	Pubblicato - 2013

Keywords

NET

Accesso al documento

10.1111/hpb.12065

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{b600ca7c3f3b4e03b97d12ca355c9dd3,

title = "Treatment of malignant pancreatic neuroendocrine neoplasms: middle-term (2-year) outcomes of a prospective observational multicentre study",

abstract = "Information on malignant pancreatic neuroendocrine neoplasms (pNENs) is mostly from retrospective studies in highly selected patients. The aim of this prospective, multicentre study was to assess treatment and outcomes of malignant pNENs in clinical practice.",

keywords = "NET, NET",

author = "Guido Rindi and Alessandro Zerbi and Vanessa Capitanio and Letizia Boninsegna and {Delle Fave}, Gianfranco and Claudio Pasquali and Davide Campana and Massimo Falconi",

year = "2013",

doi = "10.1111/hpb.12065",

language = "English",

volume = "15",

pages = "935--943",

journal = "HPB",

issn = "1365-182X",

publisher = "Martin Dunitz Limited:The Livery House, 7-9 Pratt Street, London NW1 0AE United Kingdom:011 44 20 74822202, INTERNET: http://www.dunitz.co.uk, Fax: 011 44 20 72670159",

}

Treatment of malignant pancreatic neuroendocrine neoplasms: middle-term (2-year) outcomes of a prospective observational multicentre study. / Rindi, Guido; Zerbi, Alessandro; Capitanio, Vanessa; Boninsegna, Letizia; Delle Fave, Gianfranco; Pasquali, Claudio; Campana, Davide; Falconi, Massimo.

In: HPB, Vol. 15, 2013, pag. 935-943.

Risultato della ricerca: Contributo in rivista › Articolo in rivista › peer review

TY - JOUR

T1 - Treatment of malignant pancreatic neuroendocrine neoplasms: middle-term (2-year) outcomes of a prospective observational multicentre study

AU - Rindi, Guido

AU - Zerbi, Alessandro

AU - Capitanio, Vanessa

AU - Boninsegna, Letizia

AU - Delle Fave, Gianfranco

AU - Pasquali, Claudio

AU - Campana, Davide

AU - Falconi, Massimo

PY - 2013

Y1 - 2013

N2 - Information on malignant pancreatic neuroendocrine neoplasms (pNENs) is mostly from retrospective studies in highly selected patients. The aim of this prospective, multicentre study was to assess treatment and outcomes of malignant pNENs in clinical practice.

AB - Information on malignant pancreatic neuroendocrine neoplasms (pNENs) is mostly from retrospective studies in highly selected patients. The aim of this prospective, multicentre study was to assess treatment and outcomes of malignant pNENs in clinical practice.

KW - NET

UR - http://hdl.handle.net/10807/51360

U2 - 10.1111/hpb.12065

DO - 10.1111/hpb.12065

M3 - Article

VL - 15

SP - 935

EP - 943

JO - HPB

JF - HPB

SN - 1365-182X

ER -

Treatment of malignant pancreatic neuroendocrine neoplasms: middle-term (2-year) outcomes of a prospective observational multicentre study

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo